Clinical trial
Comparison of Two Growth Hormone Dosing Methods in Adults With Growth Hormone…
NCT00490191 · Eli Lilly and Company, Industry · Completed
Key facts
| NCT number | NCT00490191 |
|---|---|
| Title | Comparison of Two Growth Hormone Dosing Methods in Adults With Growth Hormone Deficiency |
| Official title | Comparison of an Incremental Weight-Based Dose Regimen With an Individualized Dosage Adjusted According to the IGF-I Response in Adults With Growth Hormone Deficiency |
| Lead sponsor | Eli Lilly and Company, Industry |
| Status | Completed |
| Phase | Phase 4 |
| Study type | Interventional |
| Conditions | Hypopituitarism |
| Intervention type | Drug |
| Interventions | Somatropin |
| Enrollment | 387 |
| Start date | Jan 1, 1999 |
| Completion | Jul 1, 2001 |
| First posted | Jun 22, 2007 |
| Last update posted | Jun 22, 2007 |
| Countries | France, Germany, Italy, Puerto Rico, United Kingdom, United States |
At a glance
- 10–99 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: